Robert A. Wax

Array ( [id] => 707301 [patent_doc_number] => 07060442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Modulators on Nod2 signaling' [patent_app_type] => utility [patent_app_number] => 10/314506 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 45458 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060442.pdf [firstpage_image] =>[orig_patent_app_number] => 10314506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668342 [patent_doc_number] => 07094581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Hyaluronan synthases and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 10/309560 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 27313 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094581.pdf [firstpage_image] =>[orig_patent_app_number] => 10309560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972090 [patent_doc_number] => 06936475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-30 [patent_title] => 'Chimeric GFP-aequorin as bioluminescent Ca++reporters at the single cell level' [patent_app_type] => utility [patent_app_number] => 10/307389 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 18602 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936475.pdf [firstpage_image] =>[orig_patent_app_number] => 10307389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 453144 [patent_doc_number] => 07247615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'Peptide agonists of prostate-specific antigen and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/497003 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 24 [patent_no_of_words] => 26901 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247615.pdf [firstpage_image] =>[orig_patent_app_number] => 10497003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761241 [patent_doc_number] => 20030124603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Exocrine gland tight junction-constituting protein jeap family' [patent_app_type] => new [patent_app_number] => 10/298417 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8086 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124603.pdf [firstpage_image] =>[orig_patent_app_number] => 10298417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6779367 [patent_doc_number] => 20030050449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex' [patent_app_type] => new [patent_app_number] => 10/268643 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9219 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20030050449.pdf [firstpage_image] =>[orig_patent_app_number] => 10268643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792481 [patent_doc_number] => 20030087825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Method for inhibiting the formation of seromas using factor XIII' [patent_app_type] => new [patent_app_number] => 10/268180 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1379 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087825.pdf [firstpage_image] =>[orig_patent_app_number] => 10268180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 469246 [patent_doc_number] => 07232886 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-19 [patent_title] => 'Method for the manufacture of recombinant unhydroxylated collagen polypeptide fibres, and recombinant unhydroxylated collagen polypeptide fibres obtained thereby' [patent_app_type] => utility [patent_app_number] => 10/265057 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4256 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/232/07232886.pdf [firstpage_image] =>[orig_patent_app_number] => 10265057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683225 [patent_doc_number] => 20030119089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same' [patent_app_type] => new [patent_app_number] => 10/254364 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11514 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119089.pdf [firstpage_image] =>[orig_patent_app_number] => 10254364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7353336 [patent_doc_number] => 20040249139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Transductin-1 and transductin-2 and applications to hereditary deafness' [patent_app_type] => new [patent_app_number] => 10/487887 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16180 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20040249139.pdf [firstpage_image] =>[orig_patent_app_number] => 10487887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1126238 [patent_doc_number] => 06790660 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'Human kielin-like proteins and polynucleotides encoding the same' [patent_app_type] => B1 [patent_app_number] => 10/246658 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11756 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790660.pdf [firstpage_image] =>[orig_patent_app_number] => 10246658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 445722 [patent_doc_number] => 07252998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-07 [patent_title] => 'Muteins of human neutrophil gelatinase-associated lipocalin and related proteins' [patent_app_type] => utility [patent_app_number] => 10/490953 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27280 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/252/07252998.pdf [firstpage_image] =>[orig_patent_app_number] => 10490953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6657965 [patent_doc_number] => 20030078207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Engineered antibiotic peptides and the preparation thereof' [patent_app_type] => new [patent_app_number] => 10/241564 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3318 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20030078207.pdf [firstpage_image] =>[orig_patent_app_number] => 10241564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 760009 [patent_doc_number] => 07011831 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-14 [patent_title] => 'Recombinant α-galactosidase A therapy for Fabry disease' [patent_app_type] => utility [patent_app_number] => 10/234524 [patent_app_country] => US [patent_app_date] => 2002-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7033 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/011/07011831.pdf [firstpage_image] =>[orig_patent_app_number] => 10234524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 435771 [patent_doc_number] => 07262026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same' [patent_app_type] => utility [patent_app_number] => 10/487421 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 23 [patent_no_of_words] => 6142 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262026.pdf [firstpage_image] =>[orig_patent_app_number] => 10487421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1053374 [patent_doc_number] => 06858704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-22 [patent_title] => 'Peptides conferring environmental stress resistance and fusion proteins including said peptides' [patent_app_type] => utility [patent_app_number] => 10/223978 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16249 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/858/06858704.pdf [firstpage_image] =>[orig_patent_app_number] => 10223978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7379366 [patent_doc_number] => 20040028746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Crystalline drug particles prepared using a controlled precipitation (recrystallization) process' [patent_app_type] => new [patent_app_number] => 10/213907 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4181 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20040028746.pdf [firstpage_image] =>[orig_patent_app_number] => 10213907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281542 [patent_doc_number] => 20040063919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Process for the isolation and purification of a glycoprotein avidin' [patent_app_type] => new [patent_app_number] => 10/399118 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1418 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063919.pdf [firstpage_image] =>[orig_patent_app_number] => 10399118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1115855 [patent_doc_number] => 06800609 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-05 [patent_title] => 'Isolated peptide of the horny layer and user thereof' [patent_app_type] => B1 [patent_app_number] => 10/031403 [patent_app_country] => US [patent_app_date] => 2002-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7029 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/800/06800609.pdf [firstpage_image] =>[orig_patent_app_number] => 10031403 [rel_patent_id] =>[rel_patent_doc_number] =>)